![What’s behind Indian pharma cos’ global acquisition spree](https://images.assettype.com/fortuneindia%2F2022-01%2F33ee3718-a94c-40eb-abe5-25a666a20cb6%2Fbudget_Authored_articles_healthcare_2.jpg?rect=0,143,2047,1024&w=300&q=95)
What’s behind Indian pharma cos’ global acquisition spree
India's healthcare firms spent $4.32 billion during January to June of 2022 on mergers and acquisitions, compared to $2.02 billion in the same period last year
India's healthcare firms spent $4.32 billion during January to June of 2022 on mergers and acquisitions, compared to $2.02 billion in the same period last year
The Sensex and Nifty are poised to open lower on Wednesday, in line with global equities as investors remain concerned about a potential global recession.
The acquisition offers Torrent Pharma the opportunity to enhance its presence in dermatology with a differentiated portfolio.
Torrent Pharma will acquire Styptovit-E, Finast, Finast-T, and Dynapress brands from Dr Reddy’s Laboratories.